Data presented here demonstrate that Foxo1 and Foxo3 in CD4+ T cells likely act as a metabolic regulator that can suppress beiging with the potential capacity to accelerate obesity-induced insulin resistance. This evidence concerns the gene FOXO1 and obesity disorder.